Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is associated with the progression of nonalcoholic fatty liver disease (NAFLD). We hypothesized that the hypoxia of OSA increases hepatic production of lysyl oxidase (LOX), an enzyme that cross-links collagen, and that LOX may serve as a biomarker of h...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Sleep
Κύριοι συγγραφείς: Mesarwi, Omar A., Shin, Mi-Kyung, Drager, Luciano F., Bevans-Fonti, Shannon, Jun, Jonathan C., Putcha, Nirupama, Torbenson, Michael S., Pedrosa, Rodrigo P., Lorenzi-Filho, Geraldo, Steele, Kimberley E., Schweitzer, Michael A., Magnuson, Thomas H., Lidor, Anne O., Schwartz, Alan R., Polotsky, Vsevolod Y.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Associated Professional Sleep Societies, LLC 2015
Θέματα:
Lysyl Oxidase as a Biomarker of Liver Fibrosis in Severely Obese Patients with OSA
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4576332/
https://ncbi.nlm.nih.gov/pubmed/26085300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.5052
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια